COMMUNIQUÉS West-GlobeNewswire

Tetra Bio-Pharma Provides Regulatory Update for Its CAUMZ(TM) Kit
03/10/2019
U.S. Food and Drug Administration (FDA) allows evaluation of CAUMZ Kit as a combination drug/device product, providing clarity on regulatory approval pathway This is a first step in the regulatory strategy to bring [...]
Alimera Obtains Marketing Authorization for ILUVIEN® in Portugal for the Treatment of Non-Infectious Posterior Uveitis
03/10/2019
Company continues strategy to grow the use of ILUVIEN internationally through geographic expansion and further penetration into existing markets ATLANTA, Oct. 03, 2019 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (Nasdaq [...]
Corvus Pharmaceuticals to Present Updated Data from CPI-006 Clinical Trial at the Society for Immunotherapy of Cancer (SITC) Annual Meeting
03/10/2019
CPI-006 data to be presented in oral presentation and poster presentation BURLINGAME, Calif., Oct. 03, 2019 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical company [...]
Parexel Appoints John Bell Executive Vice President and Chief Quality Officer
03/10/2019
Clinical research veteran to lead Quality initiatives across global Organization in support of enhanced patient focus; appointed to company’s Executive Leadership Team DURHAM, N.C. and BOSTON, Oct. 03, 2019 (GLOBE [...]
New 48-Week Data Presented at IDWeek Show Trogarzo® Remains Safe and Effective
03/10/2019
MONTREAL, Oct. 03, 2019 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) is pleased to announce that new 48-week data from the TMB-311 extension study confirm that Trogarzo ® provides durable [...]
De nouvelles données de 48 semaines démontrent que Trogarzo(MD) demeure efficace et sécuritaire
03/10/2019
MONTRÉAL, 03 oct. 2019 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) est heureuse d’annoncer que de nouvelles données de 48 semaines issues de l’étude étendue TMB-311 confirme que Trogarzo MD [...]
REPEAT - AgraFlora Organics Prepares for October 17th Health Canada Regulations with Vertically Integrated Edibles Infrastructure, To Commercialize High-CBD Varietals Under R&D License
03/10/2019
VANCOUVER, British Columbia, Oct. 03, 2019 (GLOBE NEWSWIRE) -- AgraFlora Organics International Inc. (“ AgraFlora ” or the “ Company ”) ( CSE: AGRA) (Frankfurt: PU31) (OTCPK: AGFAF ), a growth oriented and diversified [...]
AgraFlora Organics se prépare pour les nouvelles réglementations de Santé Canada du 17 octobre avec son usine de produits comestibles verticalement intégrée en vue de commercialiser des produits à forte teneur en CBD sur réception de sa licence de R & D
03/10/2019
VANCOUVER, Colombie-Britannique, 03 oct. 2019 (GLOBE NEWSWIRE) -- AgraFlora Organics International Inc. (« AgraFlora » ou la « Société ») (CSE: AGRA) (Frankfurt: PU31) (OTCPK: AGFAF) une société internationale de [...]
ORYZON Presents New Positive REIMAGINE Efficacy Data of Vafidemstat in the Treatment of Aggression
03/10/2019
Vafidemstat reduced aggression and improved function across the three investigated psychiatric disorders, ADHD, ASD and BPD REIMAGINE data supports vafidemstat as an emerging therapeutic option in the treatment of [...]
Catalyst Biosciences Provides DalcA Phase 2b Trial Update
03/10/2019
Two subjects have successfully completed dosing, exceeded the FIX activity efficacy endpoint and no anti-drug antibodies were detected SOUTH SAN FRANCISCO, Calif., Oct. 03, 2019 (GLOBE NEWSWIRE) -- Catalyst Biosciences [...]
Spero Therapeutics Announces Positive Recommendation to Continue Phase 3 Clinical Trial of SPR994 as Planned Following Independent Review Committee Analysis of SPR994 Treated Patients in Lead-in Cohort of Trial
03/10/2019
CAMBRIDGE, Mass., Oct. 03, 2019 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq:SPRO), a multi-asset clinical-stage biopharmaceutical company focused on identifying, developing and commercializing treatments in [...]
Albireo Recognizes PFIC Awareness Day and Highlights Urgent Needs of Progressive Familial Intrahepatic Cholestasis Families
03/10/2019
Grassroots PFIC community advocates to build awareness of rare, life-threatening liver disease BOSTON, Oct. 03, 2019 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (NASDAQ: ALBO), a clinical-stage orphan pediatric liver [...]
Tonix Pharmaceuticals Announces Completion of Long-Term Exposure Studies in Participants with PTSD to Evaluate the Tolerability of TNX-102 SL 5.6 mg
03/10/2019
Company Expects this Long-Term Safety Exposure Data to Satisfy Long-Term Exposure Requirements for Potential New Drug Applications for TNX-102 SL for PTSD and Fibromyalgia NEW YORK, Oct. 03, 2019 (GLOBE NEWSWIRE) -- [...]
Kaleido Biosciences Presents Ex Vivo Data of KB109 Demonstrating Reduction of Multi-drug Resistant Pathogens at IDWeek 2019™
03/10/2019
Additional Presentation on Platform at Upcoming Keystone Symposia on the Microbiome: Therapeutic Implications LEXINGTON, Mass., Oct. 03, 2019 (GLOBE NEWSWIRE) -- Kaleido Biosciences, Inc. (Nasdaq: KLDO), a clinical- [...]
Mesoblast Completes Successful Institutional Capital Raising of A$75 Million
03/10/2019
NEW YORK, Oct. 03, 2019 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq: MESO; ASX: MSB), leader in cellular medicines for inflammatory diseases, announced today that it has successfully completed a A$75 million (US$50.4 [...]
XBiotech annonce le premier patient dans une étude clinique visant à évaluer le bermekimab pour le traitement de la sclérose systémique
03/10/2019
Le bermekimab bloque la principale voie inflammatoire dans la sclérose systémique, une maladie dévastatrice, sans thérapie approuvée à l'heure actuelle AUSTIN, Texas, 03 oct. 2019 (GLOBE NEWSWIRE) -- XBiotech (NASDAQ : [...]
MediPharm Labs Sets Date to Announce Third Quarter 2019 Financial Results
03/10/2019
TORONTO, Oct. 03, 2019 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven cannabis extraction, distillation [...]
Exactus, Inc. Launches E-Commerce Marketplace Through Exactushemp.com and Initiates Buy Back Program for Non-Traceable CBD Products
03/10/2019
DELRAY BEACH, Fla., Oct. 03, 2019 (GLOBE NEWSWIRE) -- Exactus, Inc. (OTCQB:EXDI) (the “Company”), an industrial hemp farm operator and manufacturer of hemp-derived phytocannabinoid products, today announced that it has [...]
VIVUS Initiates Pay Down of Secured Debt and Announces Management Changes
03/10/2019
-Reduction of $48.6 million of Secured Debt will result in total interest savings of $10.5 million- -Organizational change streamlines commercial operations- CAMPBELL, Calif., Oct. 03, 2019 (GLOBE NEWSWIRE) -- VIVUS, [...]

Pages